FDA Inspection 1176613 — Abbott Point of Care Canada Limited

Abbott Point of Care Canada Limited — FEI 3005643513

The FDA completed an inspection of Abbott Point of Care Canada Limited on May 19, 2022 in Nepean. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 19, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
Nepean (Canada)